These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 5748694)

  • 1. Structure of sangivamycin.
    Rao KV
    J Med Chem; 1968 Sep; 11(5):939-41. PubMed ID: 5748694
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on anti-L-1210 antibiotic produced by Streptomyces sp., No. OS-1998.
    Iwai Y; Komiyama K; Oliwa R; Awaya J; Umezawa I
    Kitasato Arch Exp Med; 1971 Dec; 44(3):205-11. PubMed ID: 5170584
    [No Abstract]   [Full Text] [Related]  

  • 3. Lavanducyanin, a new antitumor substance produced by Streptomyces sp.
    Imai S; Furihata K; Hayakawa Y; Noguchi T; Seto H
    J Antibiot (Tokyo); 1989 Jul; 42(7):1196-8. PubMed ID: 2753825
    [No Abstract]   [Full Text] [Related]  

  • 4. Cremeomycin, a novel cytotoxic antibiotic from Streptomyces cremeus. Structure elucidation and biological activity.
    McGuire JN; Wilson SR; Rinehart KL
    J Antibiot (Tokyo); 1995 Jun; 48(6):516-9. PubMed ID: 7622439
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on water-soluble antitumor antibiotics produced by Streptomyces sp., No. OS-786.
    Iwai Y; Komiyama K; Oiwa R; Awaya J; Umezawa I
    Kitasato Arch Exp Med; 1971 Jun; 44(2):95-105. PubMed ID: 5148026
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison between the inhibitory activities of sangivamycin and thiosangivamycin on nuclear ribonucleic acid synthesis in L1210 cells in vitro.
    Glazer RI; Peale AL
    Biochem Pharmacol; 1980 Feb; 29(3):305-10. PubMed ID: 7362643
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibiotics produced by Streptomyces olivaceus 142. III. Influence of antibiotic Wr 142 FPG on development of transplantable tumors in mice.
    Mordarski M; Wieczorek J
    Arch Immunol Ther Exp (Warsz); 1977; 25(6):757-64. PubMed ID: 565628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Physico-chemical properties of antineoplastic antibiotic rubomycin formed by Act. coeruleorubidus].
    Brazhnikova MG; Konstantinova NV; Pomazhova VA; Zakharov GV
    Antibiotiki; 1966 Sep; 11(9):763-7. PubMed ID: 5996873
    [No Abstract]   [Full Text] [Related]  

  • 9. Spectrophotometric determination of anthramycin.
    Stefanovich V; Ceprini MQ
    J Pharm Sci; 1971 May; 60(5):781-3. PubMed ID: 5125781
    [No Abstract]   [Full Text] [Related]  

  • 10. Damage of mammalian cell DNA in vivo and in vitro induced by neocarzinostatin.
    Tatsumi K; Nakamura T; Wakisaka G
    Gan; 1974 Oct; 65(5):459-61. PubMed ID: 4474106
    [No Abstract]   [Full Text] [Related]  

  • 11. New streptozotocin analogs with improved antileukemic activity.
    Fujiwara AN; Acton EM; Henry DW
    J Med Chem; 1974 Apr; 17(4):392-6. PubMed ID: 4275387
    [No Abstract]   [Full Text] [Related]  

  • 12. A new antitumor antimetabolite, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): antimicrobial reversal studies and preliminary evaluation against L1210 mouse leukemia in vivo.
    Hanka LJ; Martin DG; Neil GL
    Cancer Chemother Rep; 1973 Apr; 57(2):141-8. PubMed ID: 4200486
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rubomycin Q1--an anthracycline metabolite from Streptomyces coeruleorubidus 2679, a strain producing rubomycin C].
    Fedorova GB; Golova TP; Arkhangel'skaia NM; Lazhko EI; Abramova EA; Bychkova OP; Polunin AD; Katrukha GS
    Antibiot Khimioter; 1996 Mar; 41(3):3-8. PubMed ID: 8967800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement by caffeine of neocarzinostatin cytotoxicity in murine leukemia L1210 cells.
    Tatsumi K; Tashima M; Shirakawa S; Nakamura T; Uchino H
    Cancer Res; 1979 May; 39(5):1623-7. PubMed ID: 154973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of transplantability and tumor growth following treatment of L1210 leukemia and TA3Ha cells with macromomycin (NSC-170105).
    Lippman MM; Abbott BJ
    Cancer Chemother Rep; 1973; 57(4):501-3. PubMed ID: 4762442
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic performance of carminomycin-cyclophosphamide against L1210 leukemia.
    Avery TL; Cruze PG
    Cancer Res; 1978 Sep; 38(9):2892-5. PubMed ID: 679196
    [No Abstract]   [Full Text] [Related]  

  • 17. [Possibility of utilizing lymphatic leukemia L1210 as a first screening model in the primary selection of new antitumor antibiotics].
    Shorin VA; Bazhanov VS
    Antibiotiki; 1974 Aug; 19(8):679-84. PubMed ID: 4455117
    [No Abstract]   [Full Text] [Related]  

  • 18. Pyrrolopyrimidine nucleosides. 18. Synthesis and chemotherapeutic activity of 4-amino-7-(3-deoxy-beta-D-ribofuranosyl)pyrrolo[2,3-d] pyrimidine-5-carboxamide (3'-deoxysangivamycin) and 4-amino-7-(2-deoxy-beta-D-ribofuranosyl)pyrrolo[2,3-d] pyrimidine-5-carboxamide (2'-deoxysangivamycin).
    Maruyama T; Wotring LL; Townsend LB
    J Med Chem; 1983 Jan; 26(1):25-9. PubMed ID: 6827526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective tryptophan oxidation in the antitumor protein neocarzinostatin and effects on conformation and biological activity.
    Samy TS; Atreyi M; Maeda H; Meienhofer J
    Biochemistry; 1974 Feb; 13(5):1007-14. PubMed ID: 4813363
    [No Abstract]   [Full Text] [Related]  

  • 20. A facile method of purification of neocarzinostatin, an antitumor protein.
    Samy TS; Hu JM; Meienhofer J; Lazarus H; Johnson RK
    J Natl Cancer Inst; 1977 Jun; 58(6):1765-8. PubMed ID: 140942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.